INDIGO Press Releases

Catch up on the latest news and announcements from INDIGO Biosciences.

INDIGO Biosciences Wraps Up 2023 with a Record Number of New Product Releases

Nuclear Receptors and Cancer Research: Current Trends and Applications New Cell-Based Reporter Assays Included Those for Nuclear Receptors, GPCRs, and Growth Factors State College, PA (January 12th, 2024) – INDIGO Biosciences concluded 2023 with a record number of new product releases, adding 17 new assays to its portfolio of cell-based reporter gene assays targeting Nuclear…

INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Adrenergic Receptors

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Family of Assays Including ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 for Preclinical Research of Heart Failure, Hypertension, Obesity, and Respiratory Conditions State College, PA (February 21th, 2024) – INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Adrenergic…

INDIGO Biosciences Releases a Family of Cell-Based Reporter Assays for the Colony Stimulating Factor Receptors G-CSFR, M-CSFR, & GM-CSFR

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Family of Assays for Preclinical Research of Cancer, Inflammation & Autoimmune Disorders State College, PA (17 January 2024) – INDIGO Biosciences announced today the release of new cell-based reporter assays for the family of Human Colony-Stimulating Factor Receptors: Granulocyte Colony-Stimulating Factor Receptor (G-CSFR), Macrophage…

INDIGO Biosciences Releases Cell-Based Luciferase Reporter Assay for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R)

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Assay for Preclinical Research of Type II Diabetes and Obesity State College, PA (20 November 2023) – INDIGO Biosciences announced today the release of a new cell-based reporter assay for the Human Glucagon-Like Peptide-1 Receptor (GLP-1R), a member of the G protein-coupled receptor (GPCR)…

INDIGO Biosciences Releases Cell-Based Luciferase Assay for the Human Adrenoreceptor Alpha 1A (ADRA1A)

Nuclear Receptors and Cancer Research: Current Trends and Applications A New Assay for Preclinical Research of Neurological Disease, Cardiovascular Disease, and Diabetes. State College, PA  – September 25th, 2023 INDIGO Biosciences announced today the release of a new cell-based reporter assay for the Human Adrenoreceptor Alpha 1A (ADRA1A), a member of the G protein-coupled receptor…

New Assay Cell-Based Luciferase Reporter Assay developed for GM-CSFR

Nuclear Receptors and Cancer Research: Current Trends and Applications INDIGO’s New Assay for Preclinical Research of Cancer and Autoimmune Diseases GM-CSFR. State College, PA (June 27th, 2023) – Today INDIGO Biosciences announced the release of a new cell-based reporter assay for Granulocyte-Macrophage Colony-Stimulating Factor Receptor (GM-CSFR or CSF2R). This new commercially available all-inclusive assay kit…

New Environmental Monitoring and Toxicology Assays

Nuclear Receptors and Cancer Research: Current Trends and Applications INDIGO’s New Family of Assays for Environmental Monitoring and Toxicology Provide a Screening Tool for Endocrine Disrupting Chemicals. State College, PA (May 18, 2023) – Today INDIGO Biosciences released a new family of cell-based luciferase reporter assays specifically developed for use in environmental testing applications such…

INDIGO Biosciences Releases Reporter Assays for Insulin Receptor and Insulin-like Growth Factor 1 Receptor

Nuclear Receptors and Cancer Research: Current Trends and Applications Two New Assays for Preclinical Research of Cancer, Diabetes, and Cardiovascular Disease State College, PA (17 April 2023) – INDIGO Biosciences announced today the release of two new cell-based reporter assays for the Insulin Receptor, isoform B (INSRb) and Insulin-like Growth Factor 1 Receptor (IGF-1R), both…

INDIGO Biosciences Announces Record Year for 2022

Nuclear Receptors and Cancer Research: Current Trends and Applications Cell-Based Assay Solutions Provider Books Another Year of Record Growth State College, PA (February 22, 2023) – INDIGO Biosciences, Inc. (INDIGO), best known for its portfolio of cell-based luciferase reporter assays, experienced a record year of growth in 2022, with annual revenue 22% percent higher than…

Human Tropomyosin Receptor Kinase TrkA, TrkB, TrkC Assays Now Available

Nuclear Receptors and Cancer Research: Current Trends and Applications Assays for Human Tropomyosin Receptor Kinases Developed to Help Identify Inhibitors and Activators of Nerve Growth Factor Receptors. State College, PA (January 3, 2023) – INDIGO Biosciences announced today the release of three new cell-based luciferase reporter assays for Human Tropomyosin Receptor Kinases TrkA (NTRK1), TrkB…